Coronary artery perfusion during percutaneous transluminal coronary angioplasty.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000517:prevention & control; D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000379:methods*; D001802:Blood Substitutes; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control*; D003331:Coronary Vessels; D004338:Drug Combinations; D005260:Female; D005466:Fluorocarbons; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D008297:Male; D008875:Middle Aged; D010477:Perfusion; D011897:Random Allocation; D000077325:Ringer's Lactate; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000209:etiology
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D000077325:Ringer's Lactate; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination